Safety and immunogenicity of thiomersal-free recombinant hepatitis E vaccine: A randomized, double-blind, active-controlled study. Li J, Wang X, Zhang D, Xie F, et al. Vaccine 2025;62:127510.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li J, Wang X, Zhang D, Xie F, et al. Safety and immunogenicity of thiomersal-free recombinant hepatitis E vaccine: A randomized, double-blind, active-controlled study. Vaccine 2025;62:127510.
PMID: 40690851